HCM
PBYI icon

Highbridge Capital Management’s Puma Biotechnology PBYI Stock Holding History

Highbridge Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-73,864
Closed -$2.27M – 1684
2016
Q4 		$2.27M Buy
73,864
+66,985
+974% +$2.9M 0.05% 365
2016
Q3 		$462K Buy
+6,879
New +$348K 0.01% 820
2016
Q1 		– Sell
-73,899
Closed -$5.79M – 1847
2015
Q4 		$5.79M Buy
+73,899
New +$5.8M 0.11% 252
2015
Q1 		– Sell
-2,384
Closed -$451K – 1614
2014
Q4 		$451K Buy
+2,384
New +$529K 0.01% 853

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return